Mu-Hsin Chang Selected Research

Mu-Hsin Chang Research Topics

Disease

6	Fibrosis (Cirrhosis) 07/2012 - 10/2005
3	Heart Diseases (Heart Disease) 01/2012 - 10/2005
3	Cardiomegaly (Heart Hypertrophy) 01/2012 - 12/2005
3	Hypoxia (Hypoxemia) 04/2007 - 03/2007
2	Myocardial Infarction 01/2014 - 05/2009
2	Necrosis 07/2012 - 03/2007
2	Ventricular Heart Septal Defects (Ventricular Septal Defect) 04/2011 - 04/2007
2	Body Weight (Weight, Body) 10/2010 - 10/2005
2	Hypertrophy 08/2008 - 03/2007
1	Cholangiocarcinoma 08/2016
1	Neoplasm Metastasis (Metastasis) 08/2016
1	Colorectal Neoplasms (Colorectal Cancer) 04/2014
1	Mouth Neoplasms (Oral Cancer) 04/2013
1	Neoplasms (Cancer) 04/2013
1	Hypersensitivity (Allergy) 02/2012
1	Inflammation (Inflammations) 02/2012
1	Diabetes Mellitus 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Cardiomyopathies (Cardiomyopathy) 10/2010
1	Heart Failure 05/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2009
1	Tetralogy of Fallot (Fallot Tetralogy) 04/2007
1	Wounds and Injuries (Trauma) 07/2006
1	Type 2 Diabetes Mellitus (MODY) 04/2006
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2006

Drug/Important Bio-Agent (IBA)

4	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2012 - 03/2007
3	Insulin-Like Growth Factor I (IGF-1)IBA 04/2011 - 12/2005
2	EnzymesIBA 08/2016 - 07/2006
2	Proteins (Proteins, Gene)FDA Link 07/2012 - 04/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012 - 03/2007
2	Insulin-Like PeptidesIBA 04/2011 - 03/2007
2	Death Domain ReceptorsIBA 04/2007 - 10/2005
1	Aldehyde DehydrogenaseIBA 08/2016
1	Protein Isoforms (Isoforms)IBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 08/2016
1	Gemcitabine FDA Link 08/2016
1	Carboplatin (JM8)FDA LinkGeneric 04/2014
1	Cisplatin (Platino)FDA LinkGeneric 04/2014
1	CurcuminIBA 04/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Arecoline (Arecolin)IBA 04/2013
1	Tumor Biomarkers (Tumor Markers)IBA 04/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2012
1	CollagenIBA 07/2012
1	Connective Tissue Growth FactorIBA 07/2012
1	Hematoxylin (Haematoxylon)IBA 07/2012
1	Coloring Agents (Dyes)IBA 07/2012
1	Caspase 3 (Caspase-3)IBA 02/2012
1	JNK Mitogen-Activated Protein KinasesIBA 02/2012
1	bcl-Associated Death ProteinIBA 02/2012
1	OvalbuminIBA 02/2012
1	Toll-Like Receptor 4IBA 02/2012
1	Mannose (D-Mannose)IBA 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Histones (Histone)IBA 01/2012
1	Human Growth Hormone (Saizen)FDA LinkGeneric 04/2011
1	allyl sulfideIBA 10/2010
1	Streptozocin (Streptozotocin)FDA Link 10/2010
1	Matrix Metalloproteinases (MMPs)IBA 05/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2009
1	Metalloproteases (Metalloproteinases)IBA 05/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2009
1	Growth Hormone (Somatotropin)IBA 04/2007
1	RNA ProbesIBA 04/2007
1	p38 Mitogen-Activated Protein KinasesIBA 03/2007
1	InterleukinsIBA 03/2007
1	Uric Acid (Urate)IBA 04/2006
1	BilirubinIBA 04/2006
1	LipidsIBA 04/2006
1	C-Reactive ProteinIBA 04/2006
1	HomocysteineIBA 04/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2006
1	CalcineurinIBA 12/2005
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2005
1	Tobacco Smoke Pollution (Passive Smoking)IBA 10/2005
1	SmokeIBA 10/2005

Therapy/Procedure

4	Therapeutics 08/2016 - 08/2008
1	Ligation 08/2008